Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNorthern Venture Trust Regulatory News (NVT)

Share Price Information for Northern Venture Trust (NVT)

Share Price is delayed by 15 minutes
Get Live Data
55.00    0.00 (0.00%)
Bid:
53.50
Ask:
56.50
Spread: 3.00 (5.607%)
Market Cap: £143.96m
NVT Live PriceLast checked at - London Stock Exchange

Intraday Northern Venture Trust Share Chart

Net Asset Value

18 Feb 2019 15:45



Net Asset Value

18 FEBRUARY 2019

NORTHERN VENTURE TRUST PLC

UNAUDITED NET ASSET VALUE AS AT 31 DECEMBER 2018

Northern Venture Trust PLC (“the Company”) is a Venture Capital Trust (“VCT”) launched in 1995 and advised by NVM Private Equity LLP. The Company’s objective is to provide high long-term tax-free returns to investors through a combination of dividend yield and capital growth, by investing in a portfolio of investments mainly comprising unquoted venture capital holdings. In order to maintain approval by HM Revenue & Customs as a VCT, the Company is required to comply on a continuing basis with the provisions of Section 274 of the Income Tax Act 2007.

The unaudited net asset value per ordinary share as at 31 December 2018 was 68.3 pence (30 September 2018 (audited) 70.8 pence). The net asset value is stated after deducting the final dividend of 2.0 pence per share in respect of the year ended 30 September 2018, which was approved by shareholders at the annual general meeting on 14 December 2018 and was paid to eligible shareholders on 21 December 2018.

For the purposes of calculating the net asset value per share, quoted investments are carried at bid price as at 31 December 2018 and unquoted investments are carried at fair value as at 31 December 2018 as determined by the directors.

During the three months ended 31 December 2018 the following venture capital transactions took place:

New investments:

Name of company Business activity Amount invested £000
Administrate LimitedSaaS training and learning management platform797
Thanksbox LimitedEmployee engagement platform provider425

Subsequent to 31 December 2018 the Company has completed a new investment of £585,000 in Life’s Great Group (trading as Mojo Mortgages), an online mortgage broking platform.

Realisations:

 SaleOriginalCarrying value at
Name of company proceeds cost 30 September 2018
 £000£000£000
Closerstill Group – sale of company 3,035 1,747 2,598
Lanner Group – loan stock repayment 56 56 56
Sinclair Pharma (AIM quoted) – agreed takeover 490 425 476

Subsequent to 31 December 2018 the Company has completed the sale of its holding in Lanner Group, generating proceeds of £760,000 compared to a residual holding cost of £327,000.

The number of ordinary shares in issue at 31 December 2018 was 132,535,424. During the three months ended 31 December 2018 785,294 new shares were allotted at an average price of 68.8 pence per share pursuant to the Company’s dividend investment scheme and 817,318 shares were re-purchased for cancellation at a price of 64.3 pence per share.

Enquiries:Simon John/James Bryce, NVM Private Equity LLP – 0191 244 6000

Website: www.nvm.co.uk - Neither the contents of the NVM Private Equity LLP website nor the contents of any website accessible from hyperlinks on the NVM Private Equity LLP website (or any other website) is incorporated into, or forms part of, this announcement.


Date   Source Headline
27th Aug 20251:00 pmGNWTransaction in Own Shares
8th Aug 20257:00 amGNWNet Asset Value(s)
5th Aug 20254:00 pmGNWResult of AGM
31st Jul 202511:00 amGNWTotal voting rights
25th Jul 20257:00 amGNWAnnual Financial Report and Notice of AGM
3rd Jul 20257:00 amGNWTransaction in Own Shares
30th Jun 202511:00 amGNWTotal voting rights
17th Jun 20254:25 pmGNWStatement regarding intention to fundraise
17th Jun 20254:25 pmGNWDividend Declaration
17th Jun 20254:25 pmGNWAnnual Report and Financial Statements for the year ended 31 March 2025
30th May 20257:00 amGNWTotal voting rights
14th May 202510:48 amRNSTR-1: Notification of major holdings
30th Apr 202511:00 amGNWTotal voting rights
3rd Apr 202511:00 amGNWDirector/PDMR Dealings
3rd Apr 202511:00 amGNWDirector/PDMR Dealings
3rd Apr 202510:00 amGNWIssue of Equity and Total Voting Rights
31st Mar 202511:00 amGNWTotal voting rights
24th Mar 20254:30 pmGNWTransaction in Own Shares
18th Mar 20252:00 pmGNWOffer for subscription update
28th Feb 202511:00 amGNWTotal voting rights
6th Feb 20258:00 amGNWNet Asset Value
31st Jan 202511:00 amGNWTotal voting rights
22nd Jan 20258:00 amGNWIssue of Equity and Total Voting Rights
17th Jan 20254:15 pmGNWTransaction in Own Shares
14th Jan 20258:00 amGNWOffer for subscription
9th Jan 20252:00 pmGNWPublication of Prospectus
31st Dec 202411:00 amGNWTotal voting rights
4th Dec 20248:00 amGNWTransaction in Own Shares
29th Nov 202411:00 amGNWTotal voting rights
21st Nov 20243:00 pmGNWHalf-yearly report
21st Nov 20242:01 pmGNWDividend Declaration
21st Nov 20242:00 pmGNWUnaudited Half-Yearly Financial Report for the Six Months Ended 30 September 2024
31st Oct 202411:00 amGNWTotal voting rights
30th Sep 202411:00 amGNWTotal voting rights
26th Sep 20248:00 amGNWTransaction in Own Shares
23rd Sep 202410:00 amGNWStatement regarding intention to fundraise
30th Aug 202411:00 amGNWTotal voting rights
23rd Aug 20248:00 amGNWIssue of Equity and Total Voting Rights
21st Aug 202411:00 amGNWNon-Executive Director Appointment
12th Aug 20243:30 pmGNWTransaction in Own Shares
2nd Aug 20248:00 amGNWNet Asset Value
31st Jul 202411:00 amGNWTotal voting rights
30th Jul 20243:00 pmGNWResult of AGM
5th Jul 20248:00 amGNWTransaction in Own Shares
28th Jun 20243:00 pmGNWAnnual Report and Notice of AGM
28th Jun 202411:00 amGNWTotal voting rights
18th Jun 20243:01 pmGNWDividend Declaration
18th Jun 20243:00 pmGNWANNUAL FINANCIAL REPORT FOR THE YEAR ENDED 31 MARCH 2024
31st May 202411:00 amGNWTotal voting rights
30th Apr 202411:00 amGNWTotal voting rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.